UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2444-2447

2006

Link zum Volltext

Verfügbarkeit prüfen

Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling

NMR in biomedicine, 2012-02, Vol.25 (2), p.369-378

2012

Link zum Volltext

Verfügbarkeit prüfen

Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin

Biochimica et biophysica acta, 2013-03, Vol.1830 (3), p.2790-2797

2013

Link zum Volltext

Verfügbarkeit prüfen

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors

BMC cancer, 2013-10, Vol.13 (1), p.456-456, Article 456

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of the Intergroup Exemestane Study

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2507-2514

2017

Link zum Volltext

Verfügbarkeit prüfen

Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer

NMR in biomedicine, 2012-09, Vol.25 (9), p.1033-1042

2012

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibitors—Socioeconomical issues

Journal of steroid biochemistry and molecular biology, 2007-08, Vol.106 (1), p.55-61

2007

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers

Molecular cancer, 2010-07, Vol.9 (1), p.173-173, Article 173

2010

Link zum Volltext

Verfügbarkeit prüfen

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

Breast cancer research and treatment, 2001-05, Vol.67 (2), p.111-116

2001

Link zum Volltext

Verfügbarkeit prüfen

Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells

BMC cell biology, 2017-04, Vol.18 (1), p.17

2017

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibitors and inactivators for breast cancer therapy

Drugs & aging, 2002, Vol.19 (4), p.277-298

LØNNING, Per E

2002

Link zum Volltext

Verfügbarkeit prüfen

Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters

Molecular cancer, 2006-10, Vol.5, p.47-47

2006

Link zum Volltext

Verfügbarkeit prüfen

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer

International journal of cancer, 1997-02, Vol.74 (1), p.138-140

1997

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma

Cancer, 1999-02, Vol.85 (4), p.891-898

1999

Link zum Volltext

Verfügbarkeit prüfen

Aromatase Inhibition: Translation into a Successful Therapeutic Approach

Clinical cancer research, 2005-04, Vol.11 (8), p.2809-2821

2005

Link zum Volltext

Verfügbarkeit prüfen

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer

Cancer research (Chicago, Ill.), 2001-03, Vol.61 (6), p.2505-2512

2001

Link zum Volltext

Verfügbarkeit prüfen

TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer

Clinical cancer research, 2003-11, Vol.9 (15), p.5582-5588

2003

Link zum Volltext

Verfügbarkeit prüfen

Short-Term Changes in Ki-67 during Neoadjuvant Treatment of Primary Breast Cancer with Anastrozole or Tamoxifen Alone or Combined Correlate with Recurrence-Free Survival

Clinical cancer research, 2005-01, Vol.11 (2), p.951s-958s

2005

Link zum Volltext

Verfügbarkeit prüfen

Influence of Neoadjuvant Anastrozole (Arimidex) on Intratumoral Estrogen Levels and Proliferation Markers in Patients with Locally Advanced Breast Cancer

Clinical cancer research, 2001-05, Vol.7 (5), p.1230-1236

2001

Link zum Volltext

Verfügbarkeit prüfen

rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

Scientific reports, 2016-11, Vol.6 (1), p.36874, Article 36874

2016

Link zum Volltext

Verfügbarkeit prüfen

GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (14), p.5562-5571

2008

Link zum Volltext

Verfügbarkeit prüfen

Is there a growing role for endocrine therapy in the treatment of breast cancer?

Drugs (New York, N.Y.), 2000-07, Vol.60 (1), p.11-21

LØNNING, P. E

2000

Link zum Volltext

Verfügbarkeit prüfen

Interaction between p53 staining and high-dose chemotherapy in breast cancer

Clinical cancer research, 2006-04, Vol.12 (7 Pt 1), p.2289-2289

2006

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin

Oncology reports, 2005-03, Vol.13 (3), p.525

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Journals Auto-Holdings Collection

SpracheJapanisch

ThemaBreast Neoplasms - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Female
(23)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Breast Neoplasms - Drug Therapy
(18)
Oncology
(15)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Middle Aged
(11)
Breast Neoplasms - Genetics
(9)
Breast Neoplasms - Metabolism
(9)
Aged
(8)
Breast Cancer
(8)
Tumors
(8)
Chemotherapy
(7)
Antineoplastic Agents
(6)
Mutation
(6)
Pharmacology. Drug Treatments
(6)
Antineoplastic Agents - Therapeutic Use
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling

Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors

Long-Term Follow-Up of the Intergroup Exemestane Study

Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer

Aromatase inhibitors—Socioeconomical issues

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells

Aromatase inhibitors and inactivators for breast cancer therapy

Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer

Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma

Aromatase Inhibition: Translation into a Successful Therapeutic Approach

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer

TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer

Short-Term Changes in Ki-67 during Neoadjuvant Treatment of Primary Breast Cancer with Anastrozole or Tamoxifen Alone or Combined Correlate with Recurrence-Free Survival

Influence of Neoadjuvant Anastrozole (Arimidex) on Intratumoral Estrogen Levels and Proliferation Markers in Patients with Locally Advanced Breast Cancer

rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas

Is there a growing role for endocrine therapy in the treatment of breast cancer?

Interaction between p53 staining and high-dose chemotherapy in breast cancer

Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin

Aktive Filter

Suchergebnisse filtern